WEISS MICHAEL S

• NEW YORK, NY How do I update this listing?

Weiss Michael S is based out of New York. Whalewisdom has at least 9 13D filings, and 23 Form 4 filings The firm has no submitted 13F filings and does not appear to be an investment advisor.

Contact Info

weiss michael s
750 LEXINGTON AVE
NEW YORK NY 10022
Business Phone: (212) 554-4484

SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Insider Information

Manhattan Pharmaceuticals, Inc. - CEO AND PRESIDENT (07/20/2022)
Keryx Biopharmaceuticals Inc - >10% Owner (04/23/2010)
National Holdings Inc. - Director (09/12/2016)
Origo Acquisition Corp - CO-CHAIRMAN OF THE BOARD (12/12/2014)
Fortress Biotech Inc - SEE REMARKS (01/01/2022)
Checkpoint Therapeutics Inc - Director (06/16/2022)
Mustang Bio Inc - Director (06/28/2021)
Avenue Therapeutics Inc - Director (08/07/2018)
XTL Biopharmaceuticals Ltd ADR - Director (12/30/2007)
Unidentified Stock - Director (06/07/2004)
TG Therapeutics Inc - CEO AND PRESIDENT (12/29/2021)

WEISS MICHAEL S

Contact Info

Insider Information

Recent SEC Filings

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Elevate your investments

WEISS MICHAEL S

Email Notification.

Contact Info

Insider Information

Recent SEC Filings

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Elevate your investments